Discontinuation report IMURAN
Report ID | 128667 |
Drug Identification Number | 02244895 |
Brand name | IMURAN |
Common or Proper name | Imuran® Injection (azathioprine sodium) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | AZATHIOPRINE |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 vial |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-02-15 |
Actual discontinuation date | 2021-04-07 |
Remaining supply date | 2021-04-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-04-08 | English | Compare |
v10 | 2021-04-07 | French | Compare |
v9 | 2021-04-07 | English | Compare |
v8 | 2021-04-07 | English | Compare |
v7 | 2021-01-21 | French | Compare |
v6 | 2021-01-21 | English | Compare |
v5 | 2021-01-21 | English | Compare |
v4 | 2021-01-18 | French | Compare |
v3 | 2021-01-18 | English | Compare |
v2 | 2020-11-20 | French | Compare |
v1 | 2020-11-20 | English | Compare |
Showing 1 to 11 of 11